Abstract
5-Fluorouracil (5-FU) is a cytostatic agent that has been widely used in the treatment of various solid tumours for more than 20 years, and is still considered to be among the most active antineoplastic agents in advanced colorectal cancer and malignancies of the head and neck. A large number of non-chromatographic and chromatographic methods for the quantitation of 5-FU, related prodrugs and their metabolites in biological matrices have been developed in the last 30 years to support preclinical and clinical studies. However, 5-FU monitoring has not been widely used, at least not in the USA, and certainly not outside the clinical research setting, given the absence of simple, fast and inexpensive testing methods for 5-FU monitoring. Recent developments with testing based on liquid chromatography–tandem mass spectrometry and a nanoparticle antibody-based immunoassay may facilitate routine monitoring of 5-FU in daily clinical practice. In this review the advantages and disadvantages of the bioanalytical methods developed and used for 5-FU, its metabolites and related prodrugs are discussed.
Similar content being viewed by others
References
Decantris MP, Sundar S, O’Byyrme KJ (2004) Cancer Treat Rev 30:53–81
Ilson DH (2003) Cancer Treat Rev 29:525–532
Rich TA, Shepard RC, Mosley ST (2004) J Clin Oncol 22:2214–2232
Wilke HJ, Van Cutsem E (2003) Ann Oncol 14(Suppl 2):49–55
Iles SM, Gollins SW, Susnerwala S, Haylock B, Myint S, Biswas A, Swindell R, Levine E (2008) Br J Cancer 98:1210–1216
Gamelin EC, Danquechin-Dorval EM, Dumesnil YF, Maillart PJ, Goudier MJ, Burtin PC, Delva RG, Lortholary AH, Gesta PH, Larra FG (1996) Cancer 77:441–451
Grem JL (2000) Drugs 18:299–313
Longley DB, Harkin DP, Johnston PG (2003) Nat Rev Cancer 3:330–338
Diasio RB, Lu Z (1989) Clin Pharmacokinet 16:215–237
Gamelin E, Boisdron-Celle M, Larra F, Robert J (1997) J Liq Chromatogr RT 20:3155–3172
Gamelin E, Boisdron-Celle M (1999) Crit Rev Oncol Hematol 30:71–79
Friedmana MA, Ignoffob RJ (1980) Cancer Treat Rev 7:205–213
Benvenuto JA, Lu K, Hall SW, Benjamin RS, Loo TL (1978) Cancer Res 38:3867–3870
Quebbeman EJ, Hamid AAR, Hoffman NE, Ansman RK (1984) Am J Hosp Pharm 41:1153–1156
Rudy BC, Senkowski BZ (1973) In: Florey K (ed) Analytical profiles of drug substances 2. Academic, New York, pp 221–244
Kahn G, Curry MC, Dustin R (1973) Dermatologica 147:97–103
Fikus M, Wierzchowski KL, Shugar D (1964) Biochem Biophys Res Commun 16:478–483
Driessen O, DeVoss D, Timmermans PJA (1978) J Pharm Sci 67:1494–1495
Kosovec JE, Egorin MJ, Gjurich S, Beumer JH (2008) Rapid Commun Mass Spectrom 22:224–230
Joulia JM, Pinguet F, Grosse PY, Astre C, Bressolle F (1997) J Chromatogr B 692:427–435
Matsushima E, Yoshida K, Kitamura R, Yoshida KI (1997) J Chromatogr B 691:95–104
Casale F, Canapaio R, Muntoni E, Serpe L, Zara GP, Della Pepa C, Berno E, Costa M, Eandi M (2002) Biomed Chromatogr 16:446–452
Murphy RF, Balls FM, Popiack DG (1987) Clin Chem 33:2299–2300
Beumer JH, Boisdron-Celle M, Clarke W, Courtney JB, Egorin MJ, Gamelin E, Harney RL, Hammett-Stabler C, Lepp S, Li Y, Lundell GD, McMillin G, Milano G, Salamone SJ (2009) Ther Drug Monit 31:688–694
Jung M, Berger G, Pohlen U, Pauser S, Reszka R, Buhr HJ (1997) J Chromatogr B 702:193–202
Maring JG, Schouten L, Greijdanus B, De Vries EGE, Uges DRA (2005) Ther Drug Monit 27:25–30
Van den Bosch N, Driessen O, Van der Velde EA, Erkelens C (1987) Ther Drug Monit 9:443–447
Loos W, De Bruijn P, Van Zlen L, Verweij J, Nooter K, Stoter G, Sparreboom A (1999) J Chromatogr B 735:293–297
Coe RA, Earl RA, Johnson TC, Lee JW (1996) J Pharm Biomed Anal 14:1733–1741
Alsarra IA, Alarifi MN (2004) J Chromatogr B 804:435–439
Clarkson B, O’Connor A, Winston L, Hutchison D (1964) Clin Pharmacol Ther 5:581–610
Brandenberg A, Almersjo O, Falsen E, Bustavson B, Hafstrom L, Lindblom GB (1977) Acta Path Microbiol Scand B 85:227–234
Hunt DE, Pittillo RF (1968) Cancer Res 28:1095–1109
Morimoto Y, Akimoto M, Sigibayashi K, Nadai T, Kato Y (1981) Pharmazie 36:155–156
Farquharson S, Shende C, Inscore FE, Maksymiuk P, Gift A (2005) J Raman Spectrosc 36:208–212
Beumer JH, Egorin MJ, Milano G, Gamelin E, Boisdron-Celle M, Salamone SJ, Li Y, Courtney JB, Harney RL, Lundell GD (2008) In: 2008 gastrointestinal cancers symposium, Orlando, abstract 421
De Nozal MJ, Bernal JL, Pampilega A, Marinero P, Pozuelo M (1994) J Chromatogr B 656:397–405
Christophidis N, Mihaly G, Vajda F, Louis W (1979) Clin Chem 25:83–86
De Bruijn EA, Tjaden UR, Van Oosterom AT, Leeflang P, Leclercq PA (1983) J Chromatogr A 279:603–608
Wattanatorn W, McLeod HK, Cassidy J, Kendle KE (1997) J Chromatogr B 692:233–237
Jager W, Czejka MJ, Schuller J, Fogl U, Czejka E, Lackner H (1990) J Chromatogr 532:411–417
Schaaf LJ, Perry DG, Hung CT, Perrier DG, Edwards IR (1985) J Chromatogr 342:303–313
Hsu LSF, Marss TC (1980) Ann. Clin Biochem 17:272–276
Nassim MA, Shirazi FH, Cripps CM, Veerasinghan S, Molepo MJ, Obrocea M, Redmond D, Bates S, Fry D, Stewart DJ, Goel R (2002) Int J Mol Med 10:513–516
Zufia L, Aldaz A, Castellanos C, Giraldez J (2003) Ther Drug Monit 25:221–228
Barberi-Heyob M, Merlin JL, Weber B (1992) J Chromatogr 573:247–252
Barberi-Heyob M, Merlin JL, Weber B (1992) J Chromatogr 581:281–286
Stein TA, Burns GP, Bailey B, Wise L (1990) J Chromatogr A 507:259–265
Escoriaza J, Aldaz A, Calvo E, Giraldez J (1999) J Chromatogr B 736:97–102
Gamelin E, Boisdron-Celle M, Turacant A, Larra F, Allain P, Robert J (1997) J Chromatogr B 695:409–416
La Creta FP, Williams WM (1987) J Chromatogr 414:197–201
Buckpitt AR, Boyd MR (1980) Anal Biochem 106:432–437
Stetson PL, Shukla UA, Ensminger WD (1985) J Chromatogr 344:385–390
Compagnon P, Thiberville L, Moore N, Thuillez C, Lacroix C (1996) J Chromatogr B 677:380–383
Tonano JS, Vermes A, Guchelaar H-J (2001) Biomed Chromatogr 15:89–94
Jocheim C, Janning P, Marggraf U, Loffler TM, Hasse F, Linscheid M (1994) Anal Biochem 217:185–291
Anderson D, Kerr DJ, Blesing C, Seymour LW (1997) J Chromatogr B 688:87–93
Wang K, Nano M, Mulligan T, Bush ED, Edom RW (1998) J Am Soc Mass Spectrom 9:970–976
Chu D, Gua J, Liu W, Fawcett JP, Dong Q (2003) J Chromatogr B 795:377–382
Remaud G, Boisdron-Celle M, Morel A, Gamelin A (2005) J Chromatogr B 824:153–160
Finan PJ, Chisholm EM, Woodhouse L, Giles GR (1987) J Surg Oncol 13:349–353
Peters GJ, Lankelma J, Kok RM, Noordhuis P, Van Groeningen CJ, Van der Wilt CL, Meyer S, Pinedo HM (1993) Cancer Chemother Pharmacol 31:269–276
Pisano R, Breda M, Grassi S, James CA (2005) J Pharm Biomed Anal 38:738–745
Sommadossi JP, Gewirtz DA, Diasio RB, Aubert C, Cano JP, Goldman ID (1982) J Biol Chem 257:8171–8176
Tjaden UR, Lingeman H, Reuuwijk HJEM, De Bruijn EA, Keizer HJ, Van der Greef J (1988) Chromatographia 25:806–810
Kindberg CG, Slavik M, Riley CM, Stobaugh JF (1989) J Pharm Biomed Anal 7:459–469
Wung WE, Howell SB (1980) Clin Chem 26:1704–1708
Sampson DC, Fox RM (1982) Ann Clin Biochem 19:125–128
Rustum AM, Hoffman NE (1988) J Chromatogr 426:121–128
Koks CH, Van der Kam HJ, Brouwers JR (1990) Pharm Weekbl Sci 12:154–157
Smith-Rogers JA, Tong WP, Duafala ME, Markman M, Bertino JR (1991) J Chromatogr 566:147–154
Vandenbosch C, Van Belle S, De Smet M, Taton G, Bruynseels V, Vandenhoven G, Massart DL (1993) J Chromatogr 612:77–85
Wrightson WR, Myers SR, Galandiuk S (1995) Biochem Biophys Res Commun 216:808–813
Jarugula RV, Boudinot FD (1996) J Chromatogr B 677:199–203
Findlay MPN, Raynaud F, Cunningham D, Iveson A, Collins DJ, Leach MO (1996) Ann Oncol 7:47–53
Ackland SP, Garg MB, Dunstan RH (1997) Anal Biochem 246:79–85
Fruitwala MA, Sanghavi NM (1997) J Liq Chromatogr RT 20:471–480
House LK, Ramirez J, Ratain MJ (1998) J Chromatogr B 720:245–250
Casale F, Canaparo R, Serpe L, Muntoni E, Pepa CD, Costa M, Mairone L, Zara GP, Fornari G, Eandi M (2004) Pharmacol Res 50:173–179
Iwamoto M, Yoshida S, Hirose S (1984) J Chromatogr 310:151–157
Yoshida S, Hirose S, Iwamoto M (1986) J Chromatogr 383:61–68
Yamaguchi M, Nakamura M, Kuroda N, Ohkura Y (1987) Anal Sci 3:75–79
Yoshida S, Adachi T, Hirose S (1988) J Chromatogr 430:152–162
Kindberg CG, Riley CM, Stobaugh JF, Slavik M (1989) J Chromatogr 473:431–444
Uematsu T, Nakashima M, Fujii M, Hamano K, Yasutomi M, Kodaira S, Kato T, Kotabe K, Oka H, Masuike T (1996) Eur J Clin Pharmacol 50:109–113
Cohen JL, Brennan PB (1973) J Pharm Sci 62:572–575
De Leenheer AP (1979) Cosyns-Duyck MCi. J Pharm Sci 68:1174–1176
De Leenheer AP (1979) Cosyns-Duyck MCi. J Chromatogr 174:325–339
Pantarotto C, Fanelli R, Filippeschi S, Facchinetti T, Spreafico F, Salmona M (1979) Anal Biochem 97:232–238
De Bruijn EA, Driessen O, Van Den Bosch N, Van Strijen E, Slee PH Th J, Van Oosterom AT (1983) J Chromatogr 278:283–289
Kawabata N, Sugiyama S, Kuwamura T, Odaka Y, Satoh T (1983) J Pharm Sci 72:1162–1165
Williams WM, Warren BS, Lin FH (1985) Anal Biochem 147:478–486
Finj C, Sadee W (1975) Cancer Chemother Rep 59:279–286
Hillcoat BL, Kawai M, McCulloch PB, Rosenfeld J, Williams CK (1976) Br J Clin Pharmacol 3:135–143
Cano JP, Rigault JP, Aubert C, Carcassonne Y, Seitz JF (1979) Bull Cancer 66:67–74
Jones RA, Buckpitt AR, Londer HH, Myers CE, Chabner BA, Boyd MR (1979) Bull Cancer 66:75–78
MCi C-D, Cruyl AAM, De Leenheer AP, De Schrijver A, Huys JV, Belpaire FM (1980) Biomed Mass Spectrom 7:61–64
Marunaka T, Umeno Y (1980) J Chromatogr 222:382–386
Isomura H, Higuchi S, Kawamura S (1981) J Chromatogr 224:423–429
Aubert C, Sommadossi JP, Coassolo Ph, Cano JP, Rigault JP (1982) Biomed Mass Spectrom 9:336–339
Marunaka T, Umeno Y, Yoshida K et al (1980) J Pharm Sci 69:1296–1300
Aubert C, Luccioni C, Coassolo P, Sommadossi JP, Cano JP (1981) Arzneimittelforschung 31:2048–2053
Kok RM, De Jong APJM, Van Groeningen CJ, Peters GJ, Lankelma J (1985) J Chromatogr 343:59–66
Odagiri H, Dichiara S, Semura E, Uton M, Tateishi M, Kuruma I (1988) J Pharmacobiodyn 11:234–240
Bates CD, Watson DG, Willmott N, Logan H, Golberg J (1991) J Pharm Biomed Anal 9:19–21
Kubo M, Sasabe H, Shimizu T (1991) J Chromatogr 564:137–145
Van Groeningen CJ, Pinedo HM, Heddes J, Kok RM, De Jong APJM, Wattel E, Peters GJ, Lankelma J (1988) Cancer Res 48:6956–6561
Anderson LW, Parker RJ, Collins JM, Ahlgren JD, Wilkinson D, Strong JM (1992) J Chromatogr 581:195–201
Ishikawa T, Utoh M, Sawada N, Nishida M, Fukase Y, Sekiguchi F, Ishitsuka H (1998) Biochem Pharmacol 55:1091–1097
Van Kuilenburg ABP, Van Lenthe H, Maring JG, Van Gennip AH (2006) Ned Tijdschr Klin Chem Labgeneesk 31:218–219
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Breda, M., Barattè, S. A review of analytical methods for the determination of 5-fluorouracil in biological matrices. Anal Bioanal Chem 397, 1191–1201 (2010). https://doi.org/10.1007/s00216-010-3633-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-010-3633-8